By Research Area
Hot products 
-
Mouse Anti-CARTPT Recombinant Antibody (113612) (CBMAB-C2450-LY)
-
Mouse Anti-FAS2 Monoclonal Antibody (1D4) (CBMAB-0071-CN)
-
Mouse Anti-CD19 Recombinant Antibody (CBXC-1224) (CBMAB-C1491-CQ)
-
Mouse Anti-AQP2 Recombinant Antibody (G-3) (CBMAB-A3359-YC)
-
Mouse Anti-ARIH1 Recombinant Antibody (C-7) (CBMAB-A3563-YC)
-
Mouse Anti-APOH Recombinant Antibody (4D9A4) (CBMAB-A3249-YC)
-
Rat Anti-CCR2 Recombinant Antibody (475301) (CBMAB-C1338-LY)
-
Mouse Anti-C1QC Recombinant Antibody (CBFYC-0600) (CBMAB-C0654-FY)
-
Mouse Anti-EPO Recombinant Antibody (CBFYR0196) (CBMAB-R0196-FY)
-
Rabbit Anti-AP2M1 (Phosphorylated T156) Recombinant Antibody (D4F3) (PTM-CBMAB-0610LY)
-
Mouse Anti-CD33 Recombinant Antibody (P67.6) (CBMAB-C10189-LY)
-
Mouse Anti-AKR1C3 Recombinant Antibody (V2-12560) (CBMAB-1050-CN)
-
Rabbit Anti-ENO2 Recombinant Antibody (BA0013) (CBMAB-0272CQ)
-
Mouse Anti-CTCF Recombinant Antibody (CBFYC-2371) (CBMAB-C2443-FY)
-
Rabbit Anti-CCL5 Recombinant Antibody (R0437) (CBMAB-R0437-CN)
-
Mouse Anti-FN1 Monoclonal Antibody (D6) (CBMAB-1240CQ)
-
Mouse Anti-FPR2 Recombinant Antibody (1D6) (CBMAB-F2628-CQ)
-
Mouse Anti-FLI1 Recombinant Antibody (CBXF-0733) (CBMAB-F0435-CQ)
-
Mouse Anti-8-oxoguanine Recombinant Antibody (V2-7697) (CBMAB-1869CQ)
-
Mouse Anti-C5AR1 Recombinant Antibody (R63) (CBMAB-C9553-LY)
Lung Cancer Research
Lung cancer, formally known as primary bronchogenic carcinoma, originates from the epithelial cells of the bronchial mucosa or glands, which is one of the most prevalent malignancies worldwide. It is primarily classified into non-small cell lung cancer (NSCLC) and SCLC based on histopathological characteristics. While lung cancer is non-contagious, it exhibits significant familial clustering and genetic susceptibility. Common causes of lung cancer involve smoking, occupational exposure, and air pollution. According to the latest global cancer report released by the International Agency for Research on Cancer (IACR) in 2024, lung cancer ranks first in both new cases (12.4%) and deaths (18.7%), making it the leading cancer worldwide, particularly among men.
Discover our advanced antibody products, which will significantly enhance your work in lung cancer diagnosis and treatment research. These antibodies are carefully designed to possess high specificity and sensitivity, enabling accurate biomarker identification and assessment.
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Reference
- Lahiri, Aritraa, et al. "Lung cancer immunotherapy: progress, pitfalls, and promises." Molecular cancer 22.1 (2023): 40. Distributed under Open Access license CC BY 4.0. The image was modified by extracting and using only Part B of the original image.
Loading...
Compare
